论文部分内容阅读
目的:比较两组溶栓后糖尿病合并急性心肌梗死疗效和并发症。方法:2008年1月～2010年6月收治急性心肌梗死患者132例,合并糖尿病60例,未合并糖尿病72例,均在发病6～12小时内进行尿激酶溶栓治疗,比较两组溶栓后的疗效和并发症。结果:合并糖尿病组无痛性心肌梗死和多部位梗死及再梗死和并发症(心衰、心源性休克)、病死率均高于无合并组,溶栓后糖尿病组的有效率明显低于无合并组。结论:2型糖尿病并发急性心肌梗死患者的病情较重,并发症高,值得基层医院高度重视。
Objective: To compare the efficacy and complications of diabetes mellitus with acute myocardial infarction after thrombolysis in both groups. Methods: From January 2008 to June 2010, 132 patients with acute myocardial infarction, 60 with diabetes mellitus, and 72 without diabetes mellitus were treated with urokinase thrombolysis within 6 to 12 hours of onset. Thrombolysis was compared between the two groups After the efficacy and complications. Results: The pain-free myocardial infarction, multi-infarction, reinfarction and complications (heart failure, cardiogenic shock) and mortality in diabetic patients with diabetes mellitus were significantly higher than those without diabetes, and the effective rate in diabetic patients after thrombolysis was significantly lower than that in non-diabetic patients No merged group. Conclusion: Patients with type 2 diabetes mellitus complicated by acute myocardial infarction have severe illness and high complication, which is worthy of attention in primary hospitals.